[ Fondation Leenaards | Research funding on translational medical research ]

Each year, Fondation Leenaards allocates up to CHF 1.5 million for the Leenaards Prize for Translational Medical Research.
 
The research prize is awarded to 2-3 innovative projects, conducted by, at least, a university hospital (CHUV, HUG) and an academic partner (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva region, investigating a clinical problem from an original and innovative angle, linking it to a component of advanced basic research, be it experimental research, bioinformatics or epidemiological analyses.
 
The project must:

• include a human research component
• stand on its own, but it can be embedded in the context of an existing project.

• At least one group at a university hospital (CHUV or HUG) AND one group at an academic institution (e.g. EPFL, UNIL, UNIGE) of the Lake Geneva Region; the third applicant can be based outside of this region.
• The PI must be a clinical scientist (MD, MD-PhD, or PhD, below the age of 45).
• Applicants should preferably be at a relatively early stage in their careers.
• All applicants must hold a “stable position” for the entire duration of the project.
• Applicants cannot have received this grant during the last 3 years (2016-2018).

1. Deadline for Letter of Intent: 11 March 2019.
2. Pre-selection: 15 April 2019.
3. Internal deadline for Institutional Support Letter: 13 May 2019 (contact [email protected])
4. Deadline for Full Proposals: 27 May 2019
5. Final Decision: end of September 2019.
6. Beginning of the Project: early January 2020.